Chiratae Ventures Announces Second Close of Fund V at $150 Mn, Backs Healthtech & Other Startups

The fund will continue to invest across high-growth sectors, primarily AI, DeepTech, HealthTech, etc.

Bengaluru-based Venture capital firm, Chiratae Ventures, has announced the completion of the second close of its fifth fund at 150 Mn, with a final close expected in early 2026.

It aims to fulfill its commitment to backing innovative early-stage startups in India across Seed, Series A, and Series B by continuing to invest across high-growth sectors, primarily AI, DeepTech, HealthTech, ConsumerTech, FinTech, SaaS, ClimateTech, SpaceTech, and emerging fields like DefenceTech and Quantum technologies.

The Fund V, which is expected to be led by Managing Directors Venkatesh Peddi and Ranjith Menon, has emphasized the transformative role technology is playing in shaping India’s entrepreneurial ecosystem.

Commenting on this strategic investment of Chitrae Ventures, MD Menon said that “Technology is re-shaping the business landscape in unprecedented ways with the adoption of AI and the evolution of Deep-tech companies. We sense that this will be a defining decade for Indian entrepreneurship. The strong support from our investors is a validation of Chiratae’s strategy across investments and divestments.”

Adding to this, Venkatesh Peddi, Managing Director, said, “This close underscores confidence in our ability to partner with founders who will shape India’s next wave of technology companies.”

In a related development, Zealthix, a SaaS-based healthcare platform, has also raised $1.1 million in a seed funding round led by Unicorn India Ventures, with participation from AlphaGen Venture Capital.

Stay tuned for more such updates on Digital Health News